Vidarbha News

Nasopharyngeal Cancer Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

 Breaking News
  • No posts were found

Nasopharyngeal Cancer Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

June 07
19:05 2021
Nasopharyngeal Cancer Market Analysis, Leading Companies, Emerging Drugs, and Epidemiology Forecast

Delveinsight Business Research LLP

DelveInsight’s “Nasopharyngeal Cancer Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Nasopharyngeal Cancer Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Nasopharyngeal Cancer, is a type of head and neck cancer that affects the part of the throat connecting the back of the nose to the back of the mouth (nasopharynx). It should not be confused with other types of cancer that also affect the throat, such as laryngeal cancer and oesophageal cancer. Most of the nasopharyngeal cancers are nasopharyngeal carcinoma (NPC). There are mainly three types of NPC. They all start from epithelial cells that line the nasopharynx, but the cells of each type look different under a microscope. Three types include non-keratinizing undifferentiated carcinoma, non-keratinizing differentiated carcinoma, keratinizing squamous cell carcinoma.

Get FREE sample copy at:

The Nasopharyngeal Cancer Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Nasopharyngeal Cancer market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Nasopharyngeal Cancer treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Nasopharyngeal Cancer Market

Nasopharyngeal Cancer Market Key Facts

  • According to the National Health Services (NHS), men are affected about 3 times more than women by nasopharyngeal cancer.

  • According to the American Cancer Society, about half of the people with nasopharyngeal cancer in the United States are younger than 55 years old and the average age at diagnosis is about 50.

  • As per the data by Globocan, approximately 129,079 people were affected by nasopharynx cancer across the Globe in 2018, and approximately 60,558 cases were of China in 2018.

  • According to the study by Wang, Yu et al. titled “Racial differences in nasopharyngeal carcinoma in the United States” in age-specific cases the incidence rate was higher in patients more than 65 years of age, followed by patients of age between 40–64 years. The incidence rate was lower in patients of age less than 40 years. This study is the analysis of SEER data.

Key Benefits of Nasopharyngeal Cancer Market Report

  • Nasopharyngeal Cancer market report provides an in-depth analysis of Nasopharyngeal Cancer Market Size, Share, Trend, and Epidemiology Forecast till 2030 in the seven major markets (i.e. the United States, EU5 (Germany, Italy, Spain, France, and the UK) and Japan.

  • The report will help in developing business strategies by understanding the Nasopharyngeal Cancer Market Trends, recent developments, key players, and future market competition that will shape and drive the market growth in the upcoming years.

  • The market report covers the Nasopharyngeal Cancer current treatment practices, emerging drugs, market share of the individual therapies in the seven major markets.

  • The report provides a detailed assessment of the Nasopharyngeal Cancer market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Nasopharyngeal Cancer Market

The Nasopharyngeal Cancer Market Size is anticipated to increase during the forecast period owing to the rise in the number of incident cases for Nasopharyngeal Cancer in the 7MM, increase in the R&D activities and the development of targeted therapies.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Nasopharyngeal Cancer market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.

The report gives a thorough detail of the Nasopharyngeal Cancer market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. 

Nasopharyngeal Cancer Epidemiology

The epidemiology section covers insights about the historical and current Nasopharyngeal Cancer patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Nasopharyngeal Cancer Epidemiology Segmentation

  • Total Incidence of Nasopharyngeal Cancer

  • Stage-wise Incidence cases of Nasopharyngeal Cancer 

  • Gender-specific Incidence of Nasopharyngeal Cancer

  • Age-specific Incidence of Nasopharyngeal Cancer

  • Treated Pool of Nasopharyngeal Cancer

Nasopharyngeal Cancer Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Nasopharyngeal Cancer market or expected to get launched in the market during the study period. The analysis covers the Nasopharyngeal Cancer market uptake by drugs; patient uptake by therapies; and sales of each drug.   

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Nasopharyngeal Cancer Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the Nasopharyngeal Cancer market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisition, and merger, licensing, patent details, and other information for Nasopharyngeal Cancer emerging therapies.

The emerging therapeutics treatment options in Nasopharyngeal Cancer Landscape are more focused on the development of Targeted products and Immunotherapies for better efficacy.

Nasopharyngeal Cancer Companies 

  • ImClone

  • BeiGene

  • Tessa Therapeutics

  • Innovent Biologics (Suzhou)

  • Novartis Pharmaceuticals

  • Jiangsu HengRui

  • Harbour BioMed 

And many others.

The market is expected to experience positive growth in the coming years, owing to the already prescribed products along with the launch of emerging therapies. 

Nasopharyngeal Cancer Therapies covered in the report include

  • TT10

  • Tislelizumab

  • Innovent Biologics

  • Akeso Pharmaceuticals

  • Novartis Pharmaceuticals

  • Harbour BioMed

  • Cetuximab (Erbitux)

And many more.

Table of Content

1. Key Insights

2. Executive Summary 

3. Nasopharyngeal Cancer Competitive Intelligence Analysis

4. Nasopharyngeal Cancer Market Overview at a Glance

5. Nasopharyngeal Cancer Disease Background and Overview

6. Nasopharyngeal Cancer Patient Journey

7. Nasopharyngeal Cancer Epidemiology and Patient Population

8. Nasopharyngeal Cancer Treatment Algorithm, Current Treatment, and Medical Practices

9. Nasopharyngeal Cancer Unmet Needs

10. Key Endpoints of Nasopharyngeal Cancer Treatment

11. Nasopharyngeal Cancer Marketed Products

12. Nasopharyngeal Cancer Emerging Therapies

13. Nasopharyngeal Cancer Seven Major Market Analysis

14. Attribute Analysis

15. Nasopharyngeal Cancer Market Outlook (7 major markets)

16. Nasopharyngeal Cancer Access and Reimbursement Overview

17. KOL Views on the Nasopharyngeal Cancer Market.

18. Nasopharyngeal Cancer Market Drivers

19. Nasopharyngeal Cancer Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at:

Latest Reports By DelveInsight
Nasopharyngeal Cancer Pipeline Insights
Nasopharyngeal Cancer Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Nasopharyngeal Cancer market.

Healthcare Blogs –
Chronic Respiratory Diseases (CRD) Market
Despite significant research and development related to screening, diagnosis, and treatment of Chronic Respiratory Diseases (CRDs), the prevalence is continuing to rise at an alarming rate. Some of the factors such as air pollution, tobacco consumption (smoking), occupational chemicals, poor diet and nutrition, exposure to dust, and many others have led to a dramatic increase in CRD. However, to provide effective therapeutics options some of the key companies in the Chronic Respiratory Diseases (CRD) Treatment Market such as Inmunotek, Sanofi, Regeneron, Amgen, and others are actively engaged in the development of therapies. For more details, visit: Key Companies in the Chronic Respiratory Diseases (CRD) Treatment Market

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States